Evidence map›Paper›PMID 42045035›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2026

[Hollow copper sulfide nanocomposites combined with photothermal and photodynamic therapy inhibits malignant behaviors of esophageal cancer cells].

Pingjuan Yang, Anqi Ji, Shuxin Liao, Haonan Yao, Zhendong Gao, Pan Chen, Haoyan Cheng, Shegan Gao, Linlin Shi

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pingjuan YangHenan Key Laboratory of Microbiome and Esophageal Cancer Prevention and Treatment, First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang 471003, China.
Anqi JiSchool of Materials Science and Engineering, Henan University of Science and Technology, Luoyang 471023, China.
Shuxin LiaoHenan Key Laboratory of Microbiome and Esophageal Cancer Prevention and Treatment, First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang 471003, China.
Haonan YaoSchool of Materials Science and Engineering, Henan University of Science and Technology, Luoyang 471023, China.
Zhendong GaoHenan Key Laboratory of Microbiome and Esophageal Cancer Prevention and Treatment, First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang 471003, China.
Pan ChenHenan Key Laboratory of Microbiome and Esophageal Cancer Prevention and Treatment, First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang 471003, China.
Haoyan ChengSchool of Materials Science and Engineering, Henan University of Science and Technology, Luoyang 471023, China.
Shegan GaoHenan Key Laboratory of Microbiome and Esophageal Cancer Prevention and Treatment, First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang 471003, China.
Linlin ShiHenan Key Laboratory of Microbiome and Esophageal Cancer Prevention and Treatment, First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang 471003, China.

Funding

the National Clinical Key Specialty Construction Foundation of China ZLKFJJ20230401
6 · The paper itself

Abstract

objectivesTo develop a hollow Cu

methodsHollow Cu

resultsThe synthesized IR780@Cu

conclusionsThe IR780@Cu

Indexed as

CopperEsophageal NeoplasmsNanocompositesPhotochemotherapyAnimalsCell Line, TumorHumansIndolesMicePhotosensitizing AgentsPhotothermal TherapySulfides2-(2-(2-chloro-3-((1,3-dihydro-3,3-dimethyl-1-propyl-2H-indol-2-ylidene)ethylidene)-1-cyclohexen-1-yl)ethenyl)-3,3-dimethyl-1-propylindoliumCopperIndolesPhotosensitizing AgentsSulfidesCu 9 S 8esophageal cancerIR780photodynamic therapyphotothermal therapy

Identifiers

PMID42045035
PMCPMC13120981

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.